Silverarc Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Sell |
|
|||||
|
2025
Q1 | $3.74M | Sell |
|
|||||
|
2024
Q4 | $6.69M | Buy |
|
|||||
|
2024
Q3 | $4.93M | Sell |
|
|||||
|
2024
Q2 | $13.9M | Buy |
|
|||||
|
2024
Q1 | $12.6M | Buy |
|
|||||
|
2023
Q4 | $9.8M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $339K | Sell |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | $2.44M | Buy |
|
|||||
|
2022
Q3 | $1.5M | Buy |
|
|||||
|
2022
Q2 | $979K | Sell |
|
|||||
|
2022
Q1 | $256 | Buy |
|
|||||
|
2021
Q4 | $1.74M | Buy |
|
|||||
|
2021
Q3 | $2.06M | Buy |
|
|||||
|
2021
Q2 | $2.93K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.41M | Buy |
|